Literature DB >> 10071804

The vascularization of a gastric tube as a substitute for the esophagus is affected by its diameter.

J P Pierie1, P W de Graaf, T J van Vroonhoven, H Obertop.   

Abstract

The stomach is used for reconstruction of the upper gastrointestinal tract after esophageal resection for cancer. The whole stomach can be used, but also a wide or narrow gastric tube can be constructed. Short-term functional results are superior after use of a narrow tube. Healing of the cervical esophagogastrostomy can be impaired, leading to leakage and stricture. The decreased vascularization at the site of the anastomosis may be one reason. It was hypothesized that the quality of the vascularization of the gastric tube, used as a substitute for the oesophagus after esophagectomy, depends on its diameter. The vascularization of postmortem specimens was studied using angiography. Whole stomachs (3), wide (3) and narrow gastric tubes (3) were constructed. In a patient with an anastomotic stricture of a narrow tube with a cervical esophagogastrostomy vascularisation was evaluated by angiography. After infusion of contrast through the supplying arteries, the whole stomachs and wide gastric tubes showed adequate vascularization, whereas the narrow gastric tube showed poor vascularization especially at the site of the anastomosis. In narrow gastric tubes, the right gastroepiploic artery was the only feeding artery. In the patient's angiography, a limited contrast visualization of the proximal end of the gastric tube could be demonstrated. Although a narrow gastric tube is favoured by some surgeons, the use of whole stomach or a type of gastric tube with preservation of the right gastric artery may lead to a better anastomotic healing.

Entities:  

Mesh:

Year:  1998        PMID: 10071804     DOI: 10.1093/dote/11.4.231

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  8 in total

Review 1.  Managing complications II: conduit failure and conduit airway fistulas.

Authors:  Shari L Meyerson; Christopher K Mehta
Journal:  J Thorac Dis       Date:  2014-05       Impact factor: 2.895

2.  Utilization of the delay phenomenon improves blood flow and reduces collagen deposition in esophagogastric anastomoses.

Authors:  Kevin M Reavis; Eugene Y Chang; John G Hunter; Blair A Jobe
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

3.  Esophagectomy for End-Stage Achalasia.

Authors:  John Waters; Linda W Martin; Daniela Molena
Journal:  World J Surg       Date:  2022-04-03       Impact factor: 3.282

4.  Minimally invasive esophagectomy: outcomes in 222 patients.

Authors:  James D Luketich; Miguel Alvelo-Rivera; Percival O Buenaventura; Neil A Christie; James S McCaughan; Virginia R Litle; Philip R Schauer; John M Close; Hiran C Fernando
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

5.  Usefulness of blood supply visualization by indocyanine green fluorescence for reconstruction during esophagectomy.

Authors:  Yutaka Shimada; Tomoyuki Okumura; Takuya Nagata; Shigeaki Sawada; Koshi Matsui; Ryota Hori; Isaku Yoshioka; Toru Yoshida; Ryusuke Osada; Kazuhiro Tsukada
Journal:  Esophagus       Date:  2011-09-10       Impact factor: 4.230

Review 6.  Gastric-tube versus whole-stomach esophagectomy for esophageal cancer: A systematic review and meta-analysis.

Authors:  Wenxiong Zhang; Dongliang Yu; Jinhua Peng; Jianjun Xu; Yiping Wei
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

7.  The ratio of gastric tube length to thorax length: a vital factor affecting leak after esophageal cervical anastomosis.

Authors:  Xiao-Kun Li; Tian-Tian Hua; Chi Zhang; Yang Xu; Wen-Jie Wu; Chao Zheng; Gao-Ming Wang; Yong Qiang; Zhuang-Zhuang Cong; Jun Yi; Yi Shen
Journal:  Ann Transl Med       Date:  2021-03

Review 8.  The application of cell sheet engineering in the vascularization of tissue regeneration.

Authors:  Kathryn Moschouris; Negar Firoozi; Yunqing Kang
Journal:  Regen Med       Date:  2016-08-16       Impact factor: 3.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.